X4 Pharmaceuticals (XFOR) Research & Development (2018 - 2025)
Historic Research & Development for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $17.3 million.
- X4 Pharmaceuticals' Research & Development fell 957.6% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 91.87%. This contributed to the annual value of $81.6 million for FY2024, which is 1336.63% up from last year.
- As of Q3 2025, X4 Pharmaceuticals' Research & Development stood at $17.3 million, which was down 957.6% from $18.4 million recorded in Q2 2025.
- Over the past 5 years, X4 Pharmaceuticals' Research & Development peaked at $22.1 million during Q1 2023, and registered a low of $12.1 million during Q1 2021.
- In the last 5 years, X4 Pharmaceuticals' Research & Development had a median value of $17.3 million in 2025 and averaged $16.8 million.
- Per our database at Business Quant, X4 Pharmaceuticals' Research & Development skyrocketed by 5633.94% in 2022 and then plummeted by 1968.02% in 2023.
- Quarter analysis of 5 years shows X4 Pharmaceuticals' Research & Development stood at $12.2 million in 2021, then skyrocketed by 56.34% to $19.0 million in 2022, then decreased by 19.68% to $15.3 million in 2023, then surged by 42.1% to $21.7 million in 2024, then fell by 20.11% to $17.3 million in 2025.
- Its Research & Development stands at $17.3 million for Q3 2025, versus $18.4 million for Q2 2025 and $18.5 million for Q1 2025.